Tareq Abadl: CSF Culture – Understanding Cerebrospinal Fluid Testing
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“The story is about the fluid that protects the brain and spinal cord:
CSF
When a patient is admitted to the hospital with a severe headache, high fever, stiff neck, or seizures… the doctor suspects meningitis.
And that’s where the journey begins with a lumbar puncture…
A fine needle withdraws a drop of the clear fluid surrounding the nervous system.
This tiny drop is sent to the lab… and that’s where the story begins:
Direct microscopic examination:
- The first step is to place a drop of CSF on a glass slide.
We perform a Gram stain and examine it under the microscope.
If we find Gram-positive bacteria like Streptococcus pneumoniae (appearing as round, purple cells in pairs), or Gram-negative bacteria like Neisseria meningitidis (appearing as red cells in pairs), then the enemy is right in front of us.
We also look at the number and type of cells:
- The presence of many neutrophils means a severe bacterial infection.
- The presence of lymphocytes indicates a viral or fungal infection.
- The presence of yeast cells, such as Cryptococcus neoformans, can be confirmed using India ink staining.
Culture:
Place the liquid on special plates such as chocolate agar and blood agar.
Incubate for 24–48 hours.
Colonies that exhibit a distinctive appearance and odor:
Neisseria meningitidis:
- Transparent, gray colonies.
Streptococcus pneumoniae: Shiny colonies with an alpha-lysis zone.
Cryptococcus:
- White, creamy colonies.
Confirmatory Tests:
Latex agglutination:
- Rapidly detects antigens in CSF. PCR:
- The most accurate method for identifying the type of microbe.
Biochemical tests:
- Such as the oxidase test for Gram-negative bacteria.
This isn’t just about analysis…it’s a journey to find the real enemy attacking the nervous system.
Message: Direct microscopic examination with CSF culture are the first line of defense in saving a patient’s life from fatal meningitis.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI